Kwality Pharmaceuticals Limited (NSE:KPL)
India · Delayed Price · Currency is INR 3,856.40
+170.40 (4.62%)
At close: Nov 9, 2026
Kwality Pharmaceuticals Market Cap
Kwality Pharmaceuticals has a market cap or net worth of 40.02 billion as of November 10, 2026. Its market cap has increased by 348.82% in one year.
Market Cap
40.02B
Enterprise Value
41.27B
Revenue
5.54B
Global Rank
n/a
Country Rank
n/a
PE Ratio
49.38
ChartMarket Cap Chart
Since July 18, 2016, Kwality Pharmaceuticals's market cap has increased from 230.87M to 40.02B, an increase of 17,233.71%. That is a compound annual growth rate of 64.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 40.02B | 247.97% |
| Dec 31, 2025 | 11.50B | 27.87% |
| Dec 31, 2024 | 8.99B | 116.81% |
| Dec 29, 2023 | 4.15B | 5.27% |
| Dec 30, 2022 | 3.94B | -58.55% |
| Dec 31, 2021 | 9.51B | 1,561.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 84.34B |
| Sun Pharma Advanced Research Company | 62.89B |
| Innova Captab | 58.56B |
| Orchid Pharma | 51.86B |
| RPG Life Sciences | 42.33B |
| Solara Active Pharma Sciences | 30.54B |
| Ind-Swift Laboratories | 30.11B |
| Sakar Healthcare | 21.69B |